alz-journals.onlinelibrary.wiley.com

Score	Article	Date	Citations
2.1	First‐in‐Human (FIH), Single‐ and Multiple‐Ascending‐Dose (SAD/MAD) studies in healthy subjects of E2511, a novel tropomyosin receptor kinase a (TrkA) positive allosteric modulator (PAM) https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.066208	N/A	1
2.1	E2511, a novel small compound TrkA biased positive allosteric modulator, reinnervates cholinergic neuron and activates cholinergic functions in non‐clinical studies https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.062590	N/A	1
2.1	Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension study https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70905	N/A	1
2.1	Usmarapride Oxalate (SUVN-D4010): A Serotonin-4 Receptor Partial Agonist for the Treatment of Cognitive Disorders https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.062167	N/A	1
2.1	E2511, a novel small compound TrkA allosteric modulator, induces a specific trophic signaling via direct binding to TrkA, and can reverse the loss of choline acetyltransferase (ChAT) positive neurons in transgenic models of AD https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.051985	N/A	1